These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 9704018)

  • 1. 1a-docosahexaenoyl mitomycin C: a novel inhibitor of protein tyrosine kinase.
    Shikano M; Onimura K; Fukai Y; Hori M; Fukazawa H; Mizuno S; Yazawa K; Uehara Y
    Biochem Biophys Res Commun; 1998 Jul; 248(3):858-63. PubMed ID: 9704018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
    Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
    J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of protein tyrosine kinase by 5-S-GAD, a novel antibacterial substance from an insect.
    Hijikata M; Kobayashi A; Leem JY; Fukasawa H; Uehara Y; Natori S
    Biochem Biophys Res Commun; 1997 Aug; 237(2):423-6. PubMed ID: 9268727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design.
    Alfaro-Lopez J; Yuan W; Phan BC; Kamath J; Lou Q; Lam KS; Hruby VJ
    J Med Chem; 1998 Jun; 41(13):2252-60. PubMed ID: 9632358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of protein tyrosine kinase activity by 1a-docosahexaenoyl mitomycin C.
    Shikano M; Onimura K; Fukazawa H; Mizuno S; Yazawa K; Uehara Y
    Ann N Y Acad Sci; 1999; 886():269-72. PubMed ID: 10667236
    [No Abstract]   [Full Text] [Related]  

  • 6. Disruption of cell-substrate adhesion activates the protein tyrosine kinase pp60(c-src).
    Maher PA
    Exp Cell Res; 2000 Nov; 260(2):189-98. PubMed ID: 11035913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The marine natural product, halistanol trisulfate, inhibits pp60v-src protein tyrosine kinase activity.
    Slate DL; Lee RH; Rodriguez J; Crews P
    Biochem Biophys Res Commun; 1994 Aug; 203(1):260-4. PubMed ID: 8074664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
    Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
    Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice.
    Golas JM; Arndt K; Etienne C; Lucas J; Nardin D; Gibbons J; Frost P; Ye F; Boschelli DH; Boschelli F
    Cancer Res; 2003 Jan; 63(2):375-81. PubMed ID: 12543790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
    Musgrave BL; Phu T; Butler JJ; Makrigiannis AP; Hoskin DW
    Exp Cell Res; 1999 Oct; 252(1):96-103. PubMed ID: 10502402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of extracellular-regulated kinase by 5-hydroxytryptamine(2A) receptors in PC12 cells is protein kinase C-independent and requires calmodulin and tyrosine kinases.
    Quinn JC; Johnson-Farley NN; Yoon J; Cowen DS
    J Pharmacol Exp Ther; 2002 Nov; 303(2):746-52. PubMed ID: 12388661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of alpha-cyano-beta-hydroxy-beta-methyl-n-[4-(trifluoromethoxy)phe nyl]-propenamide as an inhibitor of the epidermal growth factor receptor tyrosine kinase.
    Ghosh S; Zheng Y; Jun X; Mahajan S; Mao C; Sudbeck EA; Uckun FM
    Clin Cancer Res; 1999 Dec; 5(12):4264-72. PubMed ID: 10632369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of 5-S-GAD on phosphorylation of V-SRC and BCR-ABL tyrosine kinase.
    Leem JY; Park HY; Fukazawa H; Uehara Y; Natori S
    Biol Pharm Bull; 1998 Jul; 21(7):784-5. PubMed ID: 9703270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinnamamide analogs as inhibitors of protein tyrosine kinases.
    Buzzetti F; Brasca MG; Crugnola A; Fustinoni S; Longo A; Penco S; Dalla Zonca P; Comoglio PM
    Farmaco; 1993 May; 48(5):615-36. PubMed ID: 8343210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and protein kinase C inhibitory activities of balanol analogs with replacement of the perhydroazepine moiety.
    Lai YS; Mendoza JS; Jagdmann GE; Menaldino DS; Biggers CK; Heerding JM; Wilson JW; Hall SE; Jiang JB; Janzen WP; Ballas LM
    J Med Chem; 1997 Jan; 40(2):226-35. PubMed ID: 9003521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New heterocyclic analogues of 4-(2-chloro-5-methoxyanilino)quinazolines as potent and selective c-Src kinase inhibitors.
    Barlaam B; Fennell M; Germain H; Green T; Hennequin L; Morgentin R; Olivier A; Plé P; Vautier M; Costello G
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5446-9. PubMed ID: 16203139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of protein-DNA complexes in HeLa S3 cells by KW-2149, a new derivative of mitomycin C.
    Fujii N; Arai H; Saito H; Kasai M; Nakano H
    Cancer Res; 1993 Oct; 53(19):4466-8. PubMed ID: 8402614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel compounds, '1,3-selenazine derivatives' as specific inhibitors of eukaryotic elongation factor-2 kinase.
    Cho SI; Koketsu M; Ishihara H; Matsushita M; Nairn AC; Fukazawa H; Uehara Y
    Biochim Biophys Acta; 2000 Jul; 1475(3):207-15. PubMed ID: 10913818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinase inhibitors. 4. Structure-activity relationships among N- and 3-substituted 2,2'-dithiobis(1H-indoles) for in vitro inhibition of receptor and nonreceptor protein tyrosine kinases.
    Palmer BD; Rewcastle GW; Thompson AM; Boyd M; Showalter HD; Sercel AD; Fry DW; Kraker AJ; Denny WA
    J Med Chem; 1995 Jan; 38(1):58-67. PubMed ID: 7837241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.